The No. 1 AI Stock of 2024 (Not Nvidia)
It's not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the AI boom. "This company just teamed up with one of the biggest power players in the AI industry... yet you can still buy it for just one-twelfth the price of Nvidia -- the time to buy is NOW," says Marc Chaikin.
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.
Company that made millions of defective sleep apnea machines ordered to overhaul manufacturing
WASHINGTON (AP) — The company responsible for a will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, under a announced Tuesday by federal officials.
Bill Clinton Backing Biden Replacement??? - Ad
"Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August... To become the next President of the United States. When you see who, you'll be terrified... Because if I'm right about the election outcome... I'm recommending every American make urgent moves with their money right now." --Louis Navellier
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
WASHINGTON (AP) — President Joe Biden’s administration is indefinitely delaying a , a decision that infuriated anti-smoking advocates but could avoid a political backlash from Black voters in November.
The A.I. Story Nobody is Telling You (Read ASAP) - Ad
There's been a lot of buzz surrounding A.I. over the past couple of years -- but there's only ONE story you should be worried about. Whether you have $500 or $500,000, this radical new A.I. Innovation will have a direct impact on your wealth.
What's Going On With Pfizer Stock On Thursday?
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Congo questions Apple over knowledge of conflict minerals in its supply chain
CAPE TOWN, South Africa (AP) — ’s government is questioning about the tech company’s knowledge of “blood minerals” from a conflict zone in the African country that could be smuggled into its supply chains and is demanding answers within three weeks.
What Should You Be Doing To "A.I.-Proof" Your Retirement? - Ad
A.I. is creeping into every aspect of our daily lives... According to billion-dollar fund manager Louis Navellier, it's never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.
New California rule aims to limit health care cost increases to 3% annually
SACRAMENTO, Calif. (AP) — Doctors, hospitals and health insurance companies in California will be limited to annual price increases of 3% starting in 2029 under a new rule state regulators approved Wednesday in the latest attempt to corral the ever-increasing costs of medical care in the United States.
Dairy cattle must be tested for bird flu before moving between states, agriculture officials say
Dairy cattle moving between states must be tested for the bird flu virus, U.S. agriculture officials said Wednesday as they try to track and control the growing outbreak.
Bitcoin Gained 164% in 2023 but Crypto Millionaire Abandoned It for This - Ad
A certain crypto genius and millionaire has been praising Bitcoin since it was trading for $61. Even though it gained 164% last year, he's now recommending a different cryptocurrency. In fact, he's betting his own money on and buying it like crazy.
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
Neurocrine Biosciences reports Phase 2 data for NBI-1065845 in major depressive disorder. Results show significant improvement in MADRS scores. William Blair sees the potential for $1 billion+ in sales.
Jury: BNSF Railway contributed to 2 deaths in Montana town where asbestos sickened thousands
HELENA, Mont. (AP) — A federal jury on Monday said Warren Buffett’s BNSF Railway contributed to the deaths of two people who were exposed to asbestos decades ago when tainted mining material was shipped through a Montana town where thousands have been sickened.
MUST SEE By May 1: Beware Biden's Trojan Horse - Ad
It could usher in the most radical transformation of our money we've ever seen in America's history... trigger a surprise election outcome in the coming months... and fundamentally alter the value of your savings forever. One 24-year market veteran warns that most Americans simply aren't prepared for what's coming on May 1.
BNSF Railway says it didn't know about asbestos that's killed hundreds in Montana town
HELENA, Mont. (AP) — BNSF Railway attorneys are expected to argue before jurors Friday that the railroad should not be held liable for the lung cancer deaths of two former residents of an , one of the deadliest sites in the federal Superfund pollution program.
Nevada Supreme Court rulings hand setbacks to gun-right defenders and anti-abortion activists
RENO, Nev. (AP) — Nevada's Supreme Court upheld a state ban on ghost guns Thursday, overturning a lower court's ruling that sided with a gun manufacturer's argument that the 2021 law regulating firearm components with no serial numbers was too broad and unconstitutionally vague.
America's Cash Bubble Set to Burst on May 1, 2024 - Ad
For the first time I've ever heard of... we know the exact day (and time) a bubble is going to burst. This is insane and something we only have access to because of Jason's findings (that he's sharing with his ultra-elite clients). To find out what the cash bubble is and why you're vulnerable to it without even realizing...
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data for Paxtrava also disclosed, showing substantial reduction in intraocular pressure.
Homes are demolished in Ivory Coast's main city over alleged health concerns. Thousands are homeless
ABIDJAN, Ivory Coast (AP) — Dame Touré rushed to quickly gather what she could as bulldozers rolled into her neighborhood in Ivory Coast's . Her three children joined her, stuffing plastic bags with clothes and whatever other items they could grab, before their home was reduced to rubble as armed security forces looked on.
Crypto Reboot Finally Makes An 8,788% Return Possible [NOT Bitcoin] - Ad
A crypto millionaire is revealing that a different cryptocurrency is going to do even better... It's not simply "buy the dip." Instead, it's a strategy that James learned during the dot com stock market crash. Not only has this strategy worked in a crash... it needs a crash to work best.
Cyberattack costs hit UnitedHealth in 1Q that still turns out better than expected
UnitedHealth Group trounced first-quarter expectations even as costs from a business ate into the company’s performance.
Weedkiller manufacturer seeks lawmakers' help to squelch claims it failed to warn about cancer
DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer.
"America's No. 1 Retirement Stock" (Name Inside) - Ad
According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?
With 'functional' beverages, brands rush to quench a thirst for drinks that do more than taste good
Supermarket are starting to look a lot more like a pharmacy.
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
The Man Who Bought Bitcoin at $5 Reveals His Next Tiny Crypto Gem for 2024 - Ad
Early Bitcoin Millionaire Charlie Shrem just revealed his five little-known crypto coins that he believes could create generational wealth over the next 12 months. What's more, some of these tiny cryptos he's discovered trade for less than $1!
On eve of Japanese prime minister's visit to North Carolina, Fujifilm announces more jobs there
RALEIGH, N.C. (AP) — Hours before the Japanese prime minister's arrival in North Carolina, a subsidiary of Japan's Fujifilm Corp. announced Thursday plans to expand further a massive biopharmaceutical manufacturing plant in the state, even as the initial phase is not yet complete, promising another 680 jobs.
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
America's Final Republican President - Ad
Louis Navellier believes Donald J. Trump could go down as America's last Republican president. But NOT for the reasons you may think... If he's right, the soul of this country will change forever...
Norfolk Southern agrees to pay $600M in settlement related to train derailment in eastern Ohio
Norfolk Southern has agreed to pay $600 million in a class-action lawsuit settlement related to a fiery train derailment in February 2023 in eastern Ohio.
Trial to begin against railroad over deaths in Montana town where thousands were exposed to asbestos
HELENA, Mont. (AP) — A trial begins Monday against Warren Buffett's BNSF Railway over the lung cancer deaths of two people who lived in a small northwestern Montana town where thousands of people were exposed to asbestos from a vermiculite mine.
Defi Coin Triggers All "Buy" Signals and Could Break Out Soon - Ad
Some are calling this the most promising DeFi project since Ethereum itself. Here's the #1 DeFi Coin Set to Soar. While Bitcoin grabs headlines, this lesser known DeFi coin is quietly gearing up for a monster rally. Experts say now is the time to buy before it reaches escape velocity.
Workers sue to overturn law that exempts Atlantic City casinos from indoor smoking ban
TRENTON, N.J. (AP) — Frustrated at having unsuccessfully agitated for over three years to get lawmakers to ban smoking in Atlantic City casinos, workers on Friday tried a new tactic. They filed a lawsuit to try to overturn a law that leaves casino workers as the only ones not covered by the protections of a clean workplace air act.
Long-time Teladoc leader departs as virtual care provider struggles with post-COVID tumble
The leader of struggling telemedicine provider Teladoc Health has left effective immediately, the company announced Friday.
Ukraine's "Secret Weapon" Against Russia - Ad
Ukraine has a new weapon that's never been used before in war. This "living software" has been its secret weapon against Russia. The Wall Street Journal Reports: "it's a technical revolution." Early investors can reap 5,633% gains on the small company that makes it.
ALS drug will be pulled from US market after study showed patients didn't benefit
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition.
Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China
Novo Nordisk warns of Ozempic starter kit scarcity in Germany amid ongoing supply challenges in Europe. Restrictions on off-label use emphasized, with intermittent shortages expected in 2024. Biosimilar Jiyoutai awaits approval in China. FDA tightens Mounjaro supply due to high demand.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.